Table 1.
Pathogen | Gender | Site of infection acquisition | Total N (%) | |||
---|---|---|---|---|---|---|
Female | Male | CA | HCA | Nosocomial | ||
Escherichia coli | 291 | 115 | 252 | 128 | 26 | 406 (74.9) |
Klebsiella pneumoniae | 29 | 23 | 25 | 25 | 2 | 52 (9.6) |
Proteus mirabilis | 14 | 11 | 11 | 13 | 1 | 25 (4.6) |
Pseudomonas aeruginosa | 7 | 11 | 4 | 11 | 3 | 18 (3.3) |
Klebsiella oxytoca | 2 | 9 | 6 | 3 | 2 | 11 (2.0) |
Citrobacter freundii | 1 | 5 | 2 | 3 | 1 | 6 (1.1) |
Enterobacter aerogenes | 2 | 3 | 4 | 0 | 1 | 5 (0.9) |
Enterobacter cloacae | 1 | 3 | 0 | 4 | 0 | 4 (0.7) |
Serratia marcescens | 0 | 3 | 2 | 1 | 0 | 3 (0.6) |
Acinetobacter spp. | 2 | 1 | 1 | 2 | 0 | 3 (0.6) |
Morganella morganii | 0 | 2 | 0 | 0 | 2 | 2 (0.4) |
Achromobacter spp. | 0 | 2 | 0 | 2 | 0 | 2 (0.4) |
Other | 4 | 1 | 4 | 1 | 0 | 5 (0.9) |
CA: community-acquired, HCA: healthcare-associated.